Halozyme Therapeutics
HALO
#1681
Rank
โ‚ฌ11.12 B
Marketcap
97,99ย โ‚ฌ
Share price
2.53%
Change (1 day)
46.92%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: โ‚ฌ11.12 Billion

As of September 2026 Halozyme Therapeutics has a market cap of โ‚ฌ11.12 Billion. This makes Halozyme Therapeutics the world's 1681th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ11.12 B61.32%
2025โ‚ฌ6.89 B17.16%
2024โ‚ฌ5.88 B33.24%
2023โ‚ฌ4.41 B-38.42%
2022โ‚ฌ7.17 B43.48%
2021โ‚ฌ4.99 B6.49%
2020โ‚ฌ4.69 B116.94%
2019โ‚ฌ2.16 B16.91%
2018โ‚ฌ1.85 B-23%
2017โ‚ฌ2.40 B97.63%
2016โ‚ฌ1.21 B-40.12%
2015โ‚ฌ2.03 B103.62%
2014โ‚ฌ0.99 B-19.76%
2013โ‚ฌ1.24 B117.44%
2012โ‚ฌ0.57 B-24.71%
2011โ‚ฌ0.75 B26.79%
2010โ‚ฌ0.59 B59.44%
2009โ‚ฌ0.37 B15.14%
2008โ‚ฌ0.32 B-14%
2007โ‚ฌ0.37 B-9.54%
2006โ‚ฌ0.41 B353.05%
2005โ‚ฌ92.56 M16%
2004โ‚ฌ79.79 M

End of Day market cap according to different sources

On Sep 20th, 2026 the market cap of Halozyme Therapeutics was reported to be:

โ‚ฌ11.12 Billion
by Nasdaq info icon info icon
โ‚ฌ11.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ566.97 B 4,997.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ137.37 B 1,135.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ895.89 B 7,955.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ88.69 B 697.53%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
โ‚ฌ10.27 B-7.64%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚ฌ0.99 B-91.08%๐Ÿ‡บ๐Ÿ‡ธ USA